SciELO - Scientific Electronic Library Online

 
vol.13 número1Expanding the teaching platform índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google

Compartilhar


SA Orthopaedic Journal

versão On-line ISSN 2309-8309
versão impressa ISSN 1681-150X

SA orthop. j. vol.13 no.1 Pretoria Jan./Mar. 2014

 

MESSAGE FROM THE PRESIDENT

 

'Money makes the world go round'

 

 

'Austerity' is a word that has become part of the current global lingua franca. 'Financial austerity' is a term that is used with more frequency in the healthcare environment than ever before. But what does it mean and should we be concerned about it in South Africa?

In economic terms, austerity describes policies used by government to reduce budget deficits during adverse economic conditions. Britain's David Cameron popularised the phrase 'the age of austerity' during a speech in April 2009, in which he committed to end years of excessive government spending. In South Africa we live in the shadows of projects like Nkandla and Sanral's e-toll. | I leave it to you to decide if austerity is a principle embraced by our government of the day.

What is indisputable, however, is that the current healthcare system is unsustainable. South Africa spends 8.9% of its GDP (gross domestic product) on healthcare, which compares with that of the UK. (In the USA this figure is 18%). But 60% of our healthcare budget is spent on about 8.7 million private insured lives, constituting 20% of the population, and only 40% of the budget is spent on 80% of the population, those not privately insured (about 43 million). You can certainly argue that the 40% expenditure in the public sector is not used wisely and that only 10% of the population contributes to personal income tax, but I challenge you with the thought that healthcare wastage is prevalent and enormous in both the public and private sectors.

Waste can be defined as expenditure on healthcare that can be eliminated without reducing the quality of care. Some areas of concern are: fraud, unnecessary services, inefficient care, administrative costs and inflated prices. According to a McKinsey Global Institute report,1 the US spends about $650 billion more on healthcare than other developed countries even when adjusting for the relative wealth of the US economy.

In South Africa we spend 3% more than the World Health Organisation's recommendation for a developing economy.

South Africa's 'financial cake' is limited in size. The healthcare budget is but one slice of the metaphorical cake, and orthopaedic surgery a small portion of it. An amount of R24 billion was paid to medical specialists in 2012.2 Of that, R5.1 billion was paid to pathologists and R4.27 billion to radiologists,3 totalling R9.37 billion for the two groups.

This is more than double the total of all the other specialities together (R4.63 billion). My concern is that R13.1 billion was paid for non-healthcare costs.2 Managed care has failed dismally in the USA in controlling the healthcare expenditure.41 think managed care has added to the spiralling healthcare cost rather than controlling it.

There is an onslaught on the financial position of the individual surgeon because we are soft targets. If we, as South African orthopaedic surgeons, don't protect our portion of the metaphorical cake, nobody will. The private hospital groups (R37.9 billion paid out by the medical funders to them in 2012) are strong, and the pathologists (R5.1 billion), radiologists (R4.27 billion) and anaesthesiol-ogists (R2.06 billion) have secured their 'portions'. We, as surgeons complain about those groups, but they have stood together, united in their approach of securing their 'slices'. My plea is that we stand together; we can be strong in association. This is the slogan I have chosen for my presidential term because I strongly believe in it.

Another firm belief of mine is that we should take charge and prove to the funders that we are concerned about healthcare expenditure. Prove to them that we are concerned about the wastage that occurs regularly in the care of our patients. Allow me to note a few examples.

How long does it take to transfer a patient from a hospital to a step-down facility? Is it in the interest of the individual hospital to expedite the transfer? It is definitely not, unless it is a per diem case. Is it in the interest of the attending physician (if applicable)? Definitely not, he/she is paid per hospital visit. Is it in the funders or your interest to transfer the patient as soon as possible? Of course! We should take control and drive this.

You are consulting and the patient tells you that he has left his X-rays at home, which happens to be 160 km away. What do you do? Do you request new X-rays? Is that not wastage? The same applies for blood tests.

What is your view about the 'early discharge protocol'? Although I know it might be financially beneficial, I have rejected it. Yes, I have rejected it for the wrong reasons. I have rejected it because we as orthopaedic surgeons are not in control! It is a project being forced on us, driven by an external force in conjunction with medical funders. We are not in control!

Can we gain control? I believe we can if we change our attitude.

 

What is happening globally?

Joshua Jacobs, President of the American Academy of Orthopaedic Surgeons (AAOS), has released the following statement: 'Identifying tests, procedures or treatments that show little to no value not only helps our patients by preventing unnecessary care, but will end up saving health care dollars.' The AAOS provided the following five recommendations for the 'Choose Wisely' campaign:

1. Avoid performing routine post-operative deep venous thrombosis ultrasonography screening in patients who undergo elective hip or knee arthroplasty.

2. Do not use needle lavage to treat patients with symptomatic osteoarthritis of the knee for long-term relief.

3. Do not use glucosamine and chondroitin to treat patients with symptomatic osteoarthritis of the knee.

4. Do not use lateral wedge insoles to treat patients with symptomatic medial compartment osteoarthritis of the knee.

5. Do not use post-operative splinting of the wrist after carpal tunnel release for long-term relief.

Not all the US orthopaedic surgeons agree with him, but the contrary should be proven with appropriate evidence. By 2015 the NHS in the United Kingdom needs to reduce their annual spending by £20 billion. How do they envisage doing it? Tim Briggs, President of the British Orthopaedic Association, has compiled a comprehensive report called: 'Get It Right First Time' (GIRFT). The crux of this report is that you should get the right patient to the right surgeon at the right time for the right and final procedure.

New Zealand has opted for so-called 'prioritisation'. This is the same as rationing of services. The doctors have to devise protocols. The outcome of procedures will be looked at in terms of cost efficiency. Different patients' circumstances will be compared in creating a patient-and-procedure priority list.

The common denominator in all of the above is to use evidence in decision-making. What are we doing in South Africa? I think it is high time that we start picking winner tests and procedures. In this sense I have chosen 'beneficence through evidence' as the theme for our annual scientific meeting at our 60th SAOA Congress, to be held in September 2014 in Cape Town. We should base our decisions on evidence. We should work collectively, in association, instead of individually. If we use evidence to prove our point and we do it in association, we will be strong and we will be in control.

 

Jan de Vos. President: South African Orthopaedic Association

 

References

1. Farrell, Jensen et al. Accounting for the cost of US health care: A new look at why Americans spend more. McKinsey Global Institute. December 2008.         [ Links ]

2. Press Release 16 of 2013. Regulator of Medical Schemes launches Annual Report.         [ Links ]

3. Beeld. 11/09/2013.         [ Links ]

4. Blumenthal et al. Health care spending - a giant slain or sleeping? N Engl J Med 2013;369:2551-57.         [ Links ]

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons